latrunculin-a and Amyotrophic-Lateral-Sclerosis

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease of unknown etiology. Although defects in nucleocytoplasmic transport (NCT) may be central to the pathogenesis of ALS and other neurodegenerative diseases, the molecular mechanisms modulating the nuclear pore function are still largely unknown. Here we show that genetic and pharmacological modulation of actin polymerization disrupts nuclear pore integrity, nuclear import, and downstream pathways such as mRNA post-transcriptional regulation. Importantly, we demonstrate that modulation of actin homeostasis can rescue nuclear pore instability and dysfunction caused by mutant PFN1 as well as by C9ORF72 repeat expansion, the most common mutation in ALS patients. Collectively, our data link NCT defects to ALS-associated cellular pathology and propose the regulation of actin homeostasis as a novel therapeutic strategy for ALS and other neurodegenerative diseases.

Topics: Acrylamides; Actins; Active Transport, Cell Nucleus; Amyotrophic Lateral Sclerosis; Biopsy; Bridged Bicyclo Compounds, Heterocyclic; C9orf72 Protein; Cell Line; Cerebral Cortex; Embryo, Mammalian; Fibroblasts; Humans; Microscopy, Electron, Transmission; Motor Neurons; Mutation; Nuclear Pore; Primary Cell Culture; Profilins; Protein Multimerization; Skin; Thiazoles; Thiazolidines